BackCannLabs Overview
CannLabs, Inc.

CannLabs Return on Equity

Latest ROE for CannLabs: 36.17% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

36.17%

Return on Equity

36.17%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

CannLabs (CANL) FAQ

The latest ROE for CANL is 36.17%. That is above the sector sector average of 11.64%. Investors often review this figure alongside CannLabs's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, CANL currently prints 36.17% for ROE, while the sector average sits near 11.64%. That is roughly 210.9% above the sector mean. Large gaps often invite a closer look at CannLabs's growth, margins, and balance sheet.

Return on Equity shows how effectively CannLabs converts resources into returns. At 36.17%, CANL may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CANL's ROE (36.17%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.